ASS-1 deficient bladder cancer cells are ADI-PEG-20 sensitive, activating the GCN2-eIF2α-ATF4 pathway and inducing C/EBP homologous protein (CHOP) expression. This evidence concerns the gene ASS1 and urinary bladder cancer.